MyCelx Technologies (GB:MYX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MyCelx Technologies Corporation has announced a shift in revenue recognition from Q4 2024 to Q1 2025 due to a delay in a significant Nigerian project’s milestone. Despite the postponement, the company assures no loss of revenue and minimal impact on the year-end cash balance, maintaining a positive project cash flow. Investors can expect the forthcoming Interim Results to provide further insights into the company’s progress.
For further insights into GB:MYX stock, check out TipRanks’ Stock Analysis page.